Skip to Main Content

Author Details

Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
1992
117
43
PMIDPaper TitleJournal TitlePublished Year
28376164Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst2017
33907591A BAYESIAN GRAPHICAL MODEL FOR GENOME-WIDE ASSOCIATION STUDIES (GWAS).Ann Appl Stat2016
25681989The distinct genetic pattern of ALS in Turkey and novel mutations.Neurobiol Aging2015
26307111Associations of the Insertion/Deletion Polymorphism in the ACE Gene and Risk of Gastric Cancer: A Meta-Analysis.J Gastrointest Cancer2015
24756832The impact of capsaicin intake on risk of developing gastric cancers: a meta-analysis.J Gastrointest Cancer2014
25342289Inferring gene network from candidate SNP association studies using a Bayesian graphical model: application to a breast cancer case-control study from ontario.Hum Hered2014
25052559Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.Breast J2014
23322534A meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations.Int J Colorectal Dis2013
23853209Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev2013
23991104Genome-wide copy number variation in sporadic amyotrophic lateral sclerosis in the Turkish population: deletion of EPHA3 is a possible protective factor.PLoS One2013
23704879Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2.PLoS One2013
23544013Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.PLoS Genet2013
23225146Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis.Breast Cancer Res Treat2013
23319340Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas.Proteomics2013
23301017Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia.PLoS One2013
22427832Menopausal status modifies breast cancer risk associated with the myeloperoxidase (MPO) G463A polymorphism in Caucasian women: a meta-analysis.PLoS One2012
23073772Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.Mol Biol Rep2012
22729394A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev2012
22916186ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population.PLoS One2012
22874498Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.J Mol Diagn2012
22874102Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.Epigenetics2012
22532573The role of genetic breast cancer susceptibility variants as prognostic factors.Hum Mol Genet2012
22669161Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.Br J Cancer2012
22253144Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.Hum Mutat2012
22247046Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers.Am J Epidemiol2012
22351618Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev2012
22348646Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.Breast Cancer Res2012
21281505Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry.Breast Cancer Res2011
22053997Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.Breast Cancer Res2011
22042950Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry.J Clin Oncol2011
21835029Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR).Breast Cancer Res2011
21890493Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.Hum Mol Genet2011
21597964Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.Hum Genet2011
21593217Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.Hum Mol Genet2011
21314952Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines.BMC Med Genomics2011
21483694NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells.PLoS One2011
21207416Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.Int J Cancer2011
21169536Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.J Natl Cancer Inst2011
20379847Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer.Breast Cancer Res Treat2010
21118973Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.Cancer Res2010
21060860Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.PLoS Genet2010
20830292A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance.PLoS One2010
20852631A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.Nat Genet2010
20212450DNA methylation of HOXD3 as a marker of prostate cancer progression.Lab Invest2010
20300125Family-based association study of IGF1 microsatellites and height, weight, and body mass index.J Hum Genet2010
18704680BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.Breast Cancer Res Treat2009
19920816Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).Br J Cancer2009
19656774Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.Hum Mol Genet2009
19229608Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.Breast Cancer Res Treat2009
19283074Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.PLoS One2009
  • 1 - 50 of 117

Recommended Authors

Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 11
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 11
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 9
University of British Columbia
Career Start Year 2005
Number of shared co-authors 26
The Fifth Affiliated Hospital, Sun Yat-sen University
Career Start Year 2004
Number of shared co-authors 33
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 43
National Cancer Institute
Career Start Year 2003
Number of shared co-authors 50
University of Cambridge
Career Start Year 2003
Number of shared co-authors 55
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year 2002
Number of shared co-authors 3
QIMR Berghofer Medical Research Institute
Career Start Year 2000
Number of shared co-authors 52
Instituto Nacional de Cancer, Programa de Pesquisa Clinica
Career Start Year 1999
Number of shared co-authors 8
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 9
University of Washington
Career Start Year 1996
Number of shared co-authors 10
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 15
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
College of Medicine, University of South Florida
Career Start Year 1995
Number of shared co-authors 48
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 33
South China University of Technology
Career Start Year 1992
Number of shared co-authors 6
Japanese Foundation for Cancer Research
Career Start Year 1992
Number of shared co-authors 21
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 30
Stanford University
Career Start Year 1989
Number of shared co-authors 11
University of Washington
Career Start Year 1988
Number of shared co-authors 5
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 59
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 6
Baylor College of Medicine
Career Start Year 1986
Number of shared co-authors 66
H. Lee Moffitt Cancer Center & Research Institute
Career Start Year 1985
Number of shared co-authors 54
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 60
National Cancer Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 82
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 55
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1972
Number of shared co-authors 55

Collaborators

University of Toronto
Co-authored papers 57
Co-authored papers 21
Instituto de Salud Carlos III
Co-authored papers 19
Co-authored papers 19
Mayo Clinic
Co-authored papers 19
University of Cambridge
Co-authored papers 19
QIMR Berghofer Medical Research Institute
Co-authored papers 19
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 19
Memorial University
Co-authored papers 18
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Co-authored papers 18
Co-authored papers 17
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 17
QIMR Berghofer Medical Research Institute
Co-authored papers 16
Co-authored papers 16
QIMR Berghofer Medical Research Institute
Co-authored papers 16
The Institute of Cancer Research
Co-authored papers 16
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 15
Ospedale Circolo e Fondazione Macchi
Co-authored papers 15
QIMR Berghofer Medical Research Institute
Co-authored papers 14
University of Utah
Co-authored papers 14
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 13
QIMR Berghofer Medical Research Institute
Co-authored papers 12
Pomeranian Medical University
Co-authored papers 12
University of California san francisco
Co-authored papers 11
Mayo Clinic
Co-authored papers 10
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 10
David Geffen School of Medicine, University of California los angeles
Co-authored papers 10
Guy's and St Thomas' NHS Foundation Trust
Co-authored papers 9
Co-authored papers 9
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 9